JP2004504353A - 腫瘍の処置及び診断のための医薬調製物並びに血漿の無脂質画分の調製方法 - Google Patents

腫瘍の処置及び診断のための医薬調製物並びに血漿の無脂質画分の調製方法 Download PDF

Info

Publication number
JP2004504353A
JP2004504353A JP2002513472A JP2002513472A JP2004504353A JP 2004504353 A JP2004504353 A JP 2004504353A JP 2002513472 A JP2002513472 A JP 2002513472A JP 2002513472 A JP2002513472 A JP 2002513472A JP 2004504353 A JP2004504353 A JP 2004504353A
Authority
JP
Japan
Prior art keywords
fraction
plasma
lipid
tumor
pharmaceutical preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002513472A
Other languages
English (en)
Japanese (ja)
Inventor
ベルツァ,アンドラーシュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2004504353A publication Critical patent/JP2004504353A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP2002513472A 2000-07-10 2001-07-10 腫瘍の処置及び診断のための医薬調製物並びに血漿の無脂質画分の調製方法 Pending JP2004504353A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0002597A HUP0002597A2 (hu) 2000-07-10 2000-07-10 Gyógyászati készítmény, elsősorban tumoros megbetegedések gyógyítására és diagnosztizálására és eljárás vérplazma lipidmentes frakciójának előállítására
PCT/HU2001/000078 WO2002007739A2 (en) 2000-07-10 2001-07-10 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma

Publications (1)

Publication Number Publication Date
JP2004504353A true JP2004504353A (ja) 2004-02-12

Family

ID=89978459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002513472A Pending JP2004504353A (ja) 2000-07-10 2001-07-10 腫瘍の処置及び診断のための医薬調製物並びに血漿の無脂質画分の調製方法

Country Status (19)

Country Link
US (1) US20040253317A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1333844A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2004504353A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20030016392A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1477965A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2001277630A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG107547A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0112866A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2415862A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA005415B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20030098A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP0002597A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL153867A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA03000342A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL361049A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK1282003A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2002007739A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU9903A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200300675B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200172A2 (hu) 2002-01-15 2003-11-28 András Bertha Eljárás tumorellenes hatóanyag kinyerésére
GB2405540B (en) * 2003-08-27 2006-05-10 Ron Shu-Yuen Hui Apparatus and method for providing dimming control of lamps and electrical lighting systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB791142A (en) * 1954-09-22 1958-02-26 Atsuwo Ushiyama A process for preparing antibiotic substance from special bacterium in human blood plasma and earth
GB834256A (en) * 1955-08-18 1960-05-04 Olin Mathieson Therapeutic bone mixture
US3083194A (en) * 1959-05-18 1963-03-26 Thies Karl Montmorillonite adsorption of fibrin from bovine blood plasma
JPS5357191A (en) * 1976-11-04 1978-05-24 Asahi Chem Ind Co Ltd Activated carbon for adsorption of toxin in serum
NL9001087A (nl) * 1990-05-07 1991-12-02 Harimex Ligos Bv Werkwijze voor het zuiveren van bloedplasma.
RO111332B1 (ro) * 1991-06-17 1996-09-30 Inst De Cercetari Chimico Farm Procedeu de obținere a unui produs hepatoprotector
HUP9900045A3 (en) * 1999-01-08 2001-02-28 Martyn Robertne Goeroeg Jolan Improved leukaemic blood-based product and their use in therapy

Also Published As

Publication number Publication date
CA2415862A1 (en) 2002-01-31
CN1477965A (zh) 2004-02-25
MXPA03000342A (es) 2004-12-13
YU9903A (sh) 2006-05-25
IL153867A0 (en) 2003-07-31
KR20030016392A (ko) 2003-02-26
AU2001277630A1 (en) 2002-02-05
EA005415B1 (ru) 2005-02-24
EA200300133A1 (ru) 2003-06-26
SK1282003A3 (en) 2003-08-05
ZA200300675B (en) 2004-02-19
US20040253317A1 (en) 2004-12-16
BR0112866A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-12-08
HRP20030098A2 (en) 2004-08-31
WO2002007739A3 (en) 2002-10-10
WO2002007739A2 (en) 2002-01-31
BG107547A (bg) 2004-01-30
EP1333844A2 (en) 2003-08-13
PL361049A1 (en) 2004-09-20
HUP0002597A2 (hu) 2003-01-28
WO2002007739A9 (en) 2003-10-16
HU0002597D0 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
Quan et al. Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients
EP2801371B1 (en) Bacterial compositions for the treatment of cancer
Chu et al. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro
WO1996029394A1 (en) Method for treating tumors
Nagel et al. Cell-mediated immunity against malignant melanoma in monozygous twins
Youdim et al. Thymus dependency of cells involved in transfer of delayed hypersensitivity to Listeria monocytogenes in mice
US11839648B2 (en) Autologous cancer vaccines
Weiden et al. Immune reactivity in dogs with spontaneous malignancy
CN107119015B (zh) 外泌体、其制备方法及其在制备治疗肺癌的药物中的应用
JP2004504353A (ja) 腫瘍の処置及び診断のための医薬調製物並びに血漿の無脂質画分の調製方法
US20200016197A1 (en) Methods and compositions for use in the prevention, treatment and/or alleviation of cancer
Tallberg et al. Studies on mitochondrial regulation of the genome
Drings et al. Immunomodulating activity of Rubratin
Dumonde The Role of Lymphocytes and Macrophages in the Immunological Response: XIII International Congress of Haematology, Munich, August 2–8, 1970
Mariani et al. Blood Tumors and Their Therapies
CN119894525A (zh) Mucispirillum组合物及其癌症治疗方法
Orlando A study of the relationship between immunological enhancement and inhibition of hepatoma growth in syngeneic rats
Kornblith et al. Tumor cell and host response parameters in designing brain tumor therapy
Schabel Jr et al. Leukemias Sensitive and Resistant to Alkylating Agents: Comparison With Melphalan, Cyclophosphamide, and BCNU1, 2, 3
WO2020152331A1 (en) Non-human animal models of sézary syndrome
Konsak et al. Comparison of the digestive microbiota between two divergent lines of chickens selected based on apparent metabolisable energy
Likhite et al. Quantification of CEA in Human Gastrointestinal Cancers Grown in in vitro Long-Term Organotypic Culture
Wolters Cellular and genetic requirements for graft-versus-host reactivity